5-Amino-1MQ: The Metabolic Switch Protocol
Disclaimer: This article is for educational and research purposes only. 5-Amino-1MQ is a small molecule NNMT inhibitor currently under metabolic research. It is not FDA-approved for human use. All information reflects current 2024–2026 research data.
What is 5-Amino-1MQ?
5-Amino-1MQ is a membrane-permeable small molecule that functions as a potent, selective inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT).
NNMT is primarily active in fat tissue and the liver. High levels of NNMT are strongly linked to slowed metabolism, fat accumulation, and decreased cellular energy. By "shutting off" this enzyme, 5-Amino-1MQ acts as a metabolic switch-flipper, shifting the body from fat storage to fat oxidation.
- Molecular Formula: $C_{10}H_{10}N_{2}$
- Target: Nicotinamide N-methyltransferase (NNMT)
- Classification: Small molecule / Enzyme inhibitor
Mechanism of Action: The "NAD+ Extender"
Unlike many fat burners that rely on stimulants, 5-Amino-1MQ works through high-level cellular chemistry:
- NNMT Inhibition: It blocks the enzyme that normally "consumes" nicotinamide (a precursor to NAD+).
- NAD+ Boosting: By preventing the destruction of nicotinamide, it indirectly raises intracellular NAD+ levels.
- Sirtuin Activation: Elevated NAD+ activates SIRT1 (the "longevity gene"), which promotes mitochondrial biogenesis and fat burning.
- Thermogenesis: It increases energy expenditure in white adipose tissue, essentially "heating up" fat cells to be used as fuel.
Current Research Landscape (2024–2026)
Key Study Findings
| Focus Area | Primary Outcome | Reference |
| Muscle Performance | 60% increase in grip strength when paired with exercise in aged models. | Scientific Reports (2024) |
| Fat Oxidation | Significant reduction in fat cell size and white adipose tissue mass. | Journal of Pharmacology |
| Metabolic Health | Improved insulin sensitivity and reduced liver fat accumulation. | Frontiers in Pharmacology (2026) |
Research Protocols (5mg Vial)
In research circles, 5-Amino-1MQ is often taken orally (capsules), but injectable (SubQ) protocols are frequently explored for higher bioavailability and localized fat-loss research.
Reconstitution (2 mL BAC Water)
For a 5 mg vial, adding 2 mL of Bacteriostatic Water (BAC) provides a standard research concentration.
Total Vial: 5 mg (5,000 mcg)
Concentration: 2.5 mg per 1 mL (25 mcg per unit)
Dosing Schedule (Subcutaneous)
Note: Clinical research doses for 5-Amino-1MQ are still being established. These figures reflect common experimental ranges.
| Research Level | Daily Dose | Syringe Units (IU) | Days per 5mg Vial |
| Micro-Dose | 250 mcg | 10 Units | 20 Days |
| Low Dose | 500 mcg | 20 Units | 10 Days |
| Standard Dose | 1 mg | 40 Units | 5 Days |
| High Dose | 2 mg | 80 Units | 2.5 Days |
Frequently Asked Questions
Does it cause the "jitters"?
No. 5-Amino-1MQ is non-stimulatory. It does not affect the central nervous system, heart rate, or blood pressure. Its energy boost comes from improved mitochondrial efficiency (ATP), not adrenaline.
When should it be administered?
Most researchers prefer morning administration. Because it increases metabolic rate and ATP production, taking it during the active window of the day aligns best with natural circadian metabolic rhythms.
Can it be stacked with NAD+?
Yes. In fact, this is one of the most popular 2026 research "stacks." While NAD+ injections provide the "fuel," 5-Amino-1MQ acts as the "mechanic" that prevents the fuel from being wasted by the NNMT enzyme.
Is it stable after reconstitution?
5-Amino-1MQ is quite stable in solution. However, it should be kept refrigerated (2-8°C) and shielded from light. Use the reconstituted vial within 30 days.
Summary Checklist
- [ ] 1 Vial 5-Amino-1MQ (5 mg).
- [ ] 2 mL Bacteriostatic Water.
- [ ] Morning administration (Subcutaneous).
- [ ] Storage: Refrigerator only.